Checkmate Pharmaceuticals

company

About

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$27M
Industries
Biotechnology,Medical Device,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Checkmate Pharma is a clinical-stage biopharmaceutical company developing a new approach for cancer immunotherapy. The clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. They leveraging their expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers.

Checkmate Pharmaceutical was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$27M
Checkmate Pharmaceuticals has raised a total of $27M in funding over 2 rounds. Their latest funding was raised on Jun 15, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 15, 2017 Series B $27M 1 Auspitz Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Checkmate Pharmaceuticals is funded by 1 investors. Auspitz are the most recent investors.
Investor Name Lead Investor Funding Round
Auspitz Yes Series B